Current Opinion in Supportive and Palliative Care was launched in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of supportive and palliative care are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
David C. Currow
Professor David Currow is currently the foundation Chief Executive Officer of Cancer Australia, the Australian government's national cancer control agency. He continues to hold the appointment of Professor of Palliative and Supportive Services at Flinders University, Adelaide, Australia.
David initially trained as a physician in internal medicine with sub-speciality training in palliative medicine. At the same time, he completed a Master of Public Health exploring changes in the reported incidence of cancer unknown primary in New South Wales over a 25 year time period. Former roles include foundation Director of the Nepean Cancer Care Centre, Sydney and Area Director of Palliative Services Wentworth Area Health Service, Sydney. Since 2000 he has had the Chair of Palliative and Supportive Services at Flinders University where there are more than 200 distance students studying at a post-graduate level around the world from a variety of discipline backgrounds. He has published widely in palliative care journals and the general medical literature. Among other projects, he is co-chief investigator on an anthology of evidence for palliative care practice and service delivery – www.caresearch.com.au. Other research interests include the symptomatic management of dyspnoea, improving population based planning for people with life limiting illnesses and improving the evidence base around which clinical decisions are made in palliative care.
David holds grants from the National Health and Medical Research Council, the National Institutes of Health (USA) and the Cancer Council Australia. He continues on the Board of the International Association of Hospice and Palliative Care and has been on the American Society of Clinical Oncology (ASCO) taskforce on palliative care education. He is a former president of the Clinical Oncological Society of Australia and a former president of Palliative Care Australia, the peak body for palliative care in the country. He is a senior associate editor of the Journal of Palliative Medicine and an associate editor of BioMed Central Palliative Care.
Since October 2006 David has been foundation Chief Executive Officer of Cancer Australia. He, together with a dedicated team are leading the government's agenda in improving coordination of cancer control, targeted research with better coordination between research funders, and consumer engagement. In February 2007, the government also asked Cancer Australia to take leadership of the National Centre for Gynaecological Cancers. The agency currently administers jointly with funding partners more than AU$20m per year in grants for projects and programs to improve cancer service delivery and cancer research.
Dr Abernethy is Associate Professor of Medicine with Tenure in the Division of Medical Oncology at Duke University School of Medicine, Associate Professor of Nursing at Duke University School of Nursing, Associate Director of Information Technology and Informatics at the Duke Comprehensive Cancer Center, Acting Program Leader for the Program in Cancer Prevention, Detection and Control Research of Duke Comprehensive Cancer Center, Medical Director for Oncology Quality, Outcomes & Patient-Centered Care in Duke University Health System, and Associate Lecturer on the Faculty of Health Sciences at Flinders University in South Adelaide, Australia. She holds affiliations with the Duke Clinical Research Institute and Duke Center for Clinical Health Policy Research.
A United States National Institutes of Health funded Principal Investigator, she founded and directs the Duke Cancer Care Research Program, conducting a large portfolio of clinical trials designed to generate evidence-based solutions for common problems confronting people with advanced life-limiting illness. Studies investigate novel agents as well as non-pharmacologic approaches to alleviate symptoms such as dyspnea, pain, and anorexia/cachexia, and study new service delivery models to optimize the cancer patient experience and quality of life.
In addition, Dr Abernethy serves on the Board of Directors for the American Academy of Hospice and Palliative Medicine, and is the Editor-in-Chief of PC-FACS, an electronic journal for palliative care practitioners. She is a practicing hematologist/oncologist and palliative medicine physician.
Richard Langford is Consultant in Anaesthesia and Pain Medicine, and Director of the Pain and Anaesthesia Research Centre at Barts and The London NHS Trust. In addition he is Reader at Barts and The London School of Medicine and Dentistry, Queen Mary College, University of London, and visiting Professor, City University, London. From 2002 he has held joint Trust and School appointments as Clinical Director of the Clinical Research Centres and Deputy Director of Research and Development.
He founded the Barts Pain and Anaesthesia Research Centre in 2000, which to date has conducted over 100 clinical trials. Other research interests include patient monitoring, including depth of anaesthesia and cerebral monitoring during surgery and intensive care, and the development of innovative opto-electronic oxygen probes.
He has served as an elected member of the Council of the British Pain Society from 2006, and for the past two years as Chairman of the Science and Research Committee. He is Associate Editor (Europe) of the International Journal of Acute Pain.
He has held Royal College and Deanery postgraduate training posts including Regional Advisor and Head of the Barts and The London School of Anaesthesia, and in 2000, founded the Barts and The London Medical Simulation Centre.